Literature DB >> 18609253

The additional value of routine electrocardiograms in cardiovascular risk management of older people.

Wouter De Ruijter1, Willem J J Assendelft, Peter W Macfarlane, Rudi G J Westendorp, Jacobijn Gussekloo.   

Abstract

OBJECTIVE: To evaluate whether routinely performed ECGs in older people from the general population have added value for cardiovascular risk management beyond the information that is already available from their medical records.
DESIGN: Observational, prospective cohort study.
SETTING: General population.
SUBJECTS: A total of 566 participants aged 85 years (377 women, 189 men).
METHODS: Lifelong history of cardiovascular disease was assessed through medical records obtained from general practitioners. Baseline ECGs were evaluated for prior myocardial infarction and atrial fibrillation. During a 5-year follow-up period, complete cardiovascular mortality and morbidity data were gathered.
RESULTS: During 5 years of follow-up, 262/566 (46%) participants died, of whom 102/262 (39%) died from cardiovascular disease. Participants with a history of cardiovascular disease at age 85 years (284/566, 50%) had an increased cardiovascular mortality (HR 2.7, 95% CI 1.8-4.1) and morbidity (HR (myocardial infarction) 2.1, 95% CI 1.3-3.6; HR (stroke) 2.7, 95% CI 1.6-4.9) compared with those without such a history. Participants with major ECG abnormalities (102/566, 18%) had an increased cardiovascular mortality (HR 1.8, 95% CI 1.1-2.8), but no increase of cardiovascular morbidity compared with those without major ECG abnormalities. In both participants with and without a history of cardiovascular disease, the presence of major ECG abnormalities was not associated with increased cardiovascular mortality or morbidity.
CONCLUSIONS: In older people from the general population, a history of cardiovascular disease is a strong predictor of cardiovascular mortality and morbidity. Although abnormal findings on routine ECGs predict cardiovascular mortality, they do not provide additional prognostic information beyond the information available from medical records. Therefore, when accurate medical records are available, programmatic ECG recording is not effective in older people.

Entities:  

Mesh:

Year:  2008        PMID: 18609253      PMCID: PMC3409602          DOI: 10.1080/02813430802095812

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  27 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

Authors:  D Hunt; P Young; J Simes; W Hague; S Mann; D Owensby; G Lane; A Tonkin
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

3.  Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly.

Authors:  S E Sheifer; B J Gersh; N D Yanez; P A Ades; G L Burke; T A Manolio
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

4.  Electronic health records, after-hours care lag in US primary care practices.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

5.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

6.  Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial.

Authors:  Timo E Strandberg; Kaisu H Pitkala; Saila Berglind; Markku S Nieminen; Reijo S Tilvis
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

7.  Statin therapy and the elderly: SAGE advice?

Authors:  Antonio M Gotto
Journal:  Circulation       Date:  2007-02-13       Impact factor: 29.690

8.  Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.

Authors:  Li Wei; Shah Ebrahim; Christopher Bartlett; Peter D Davey; Frank M Sullivan; Thomas M MacDonald
Journal:  BMJ       Date:  2005-03-24

9.  The routine electrocardiogram for cardiovascular risk stratification in old age: the Leiden 85-plus study.

Authors:  Wouter de Ruijter; Rudi G J Westendorp; Peter W Macfarlane; J Wouter Jukema; Willem J J Assendelft; Jacobijn Gussekloo
Journal:  J Am Geriatr Soc       Date:  2007-06       Impact factor: 5.562

10.  Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.

Authors:  Sheena E Ramsay; Peter H Whincup; Debbie A Lawlor; Olia Papacosta; Lucy T Lennon; Mary C Thomas; Shah Ebrahim; Richard W Morris
Journal:  BMJ       Date:  2006-01-09
View more
  5 in total

1.  Association of major and minor ECG abnormalities with coronary heart disease events.

Authors:  Reto Auer; Douglas C Bauer; Pedro Marques-Vidal; Javed Butler; Lauren J Min; Jacques Cornuz; Suzanne Satterfield; Anne B Newman; Eric Vittinghoff; Nicolas Rodondi
Journal:  JAMA       Date:  2012-04-11       Impact factor: 56.272

2.  Reasons for ordering laboratory tests and relationship with frequency of abnormal results.

Authors:  Paul H H Houben; Ron A G Winkens; Trudy van der Weijden; Renee C R M Vossen; André J M Naus; Richard P T M Grol
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

Review 3.  Systematic screening for the detection of atrial fibrillation.

Authors:  Patrick S Moran; Conor Teljeur; Mairin Ryan; Susan M Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-06-03

4.  Electrocardiograms of adult outpatients followed-up in basic health care units in the community of the South region of São Paulo City.

Authors:  Alice T Yamada; Renata X Baldow; Carla Ribeiro; Wilma N Ribeiro; Carolina Peruzzi; Nilce M Matsuda; Alfredo J Mansur
Journal:  Perm J       Date:  2014-03-31

5.  Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

Authors:  Wouter de Ruijter; Rudi G J Westendorp; Willem J J Assendelft; Wendy P J den Elzen; Anton J M de Craen; Saskia le Cessie; Jacobijn Gussekloo
Journal:  BMJ       Date:  2009-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.